Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Teleflex
TFX
Teleflex
Rising Cost Pressures And Supply Risks Will Shrink Healthcare Prospects
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
22 Apr 25
Updated
09 Aug 25
1
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$120.00
7.8% overvalued
intrinsic discount
09 Aug
US$129.42
Loading
1Y
-46.6%
7D
7.2%
Author's Valuation
US$120.0
7.8% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
1
Shared on
07 May 25
Fair value Decreased 11%
Read more
0
votes
Share
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$120.0
7.8% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
4b
2014
2017
2020
2023
2025
2026
2028
Revenue US$3.6b
Earnings US$384.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.91%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.30%
Calculation
US$384.15m
Earnings '28
x
14.32x
PE Ratio '28
=
US$5.50b
Market Cap '28
US$5.50b
Market Cap '28
/
36.46m
No. shares '28
=
US$150.87
Share Price '28
US$150.87
Share Price '28
Discounted to 2025 @ 8.39% p.a.
=
US$118.47
Fair Value '25
